Pharmaceuticals

5AM Ventures is a leading life science venture capital firm focused on funding and building next-generation life sciences companies. They primarily invest in early-stage private therapeutic companies, with an emphasis on Series A, and also invest in small and mid-cap public and later-stage private biotech and life science companies.

Axil Capital is a venture capital firm specializing in biomedical and healthcare technology investments. They focus on supporting the growth of early-stage ventures and leveraging their global network to create synergies between the Japanese and global biotech ecosystems. Their investments span the full spectrum of the life science industry, from seed to crossover rounds.

Columbus Venture Partners invests in early-stage opportunities in the life science industry.

DAG Ventures is a mid-stage venture capital partnership focused on providing service-oriented support to visionary entrepreneurs and early-stage VCs. They lead mid-stage and growth financing rounds into promising portfolio companies. Their investment model emphasizes differentiation through superior service to LPs, portfolio companies, and early-stage VC partnerships.

Firstime Ventures invests in companies building a sustainable and accessible future. They focus on entrepreneurs with impactful products and clear business models, addressing urgent challenges like climate change and accessible healthcare. Their investment strategy aligns with the United Nations Sustainable Development Goals.

Fountain Healthcare Partners is a venture fund providing risk capital and expertise to life sciences companies. They focus on a limited number of portfolio companies to provide extensive support beyond capital, acting as true partners in growth and risk mitigation. Their investments span from seed stage to public offerings, with a majority in Europe and the remainder in the US.

Genesys Capital is a life science venture capital firm that invests in and builds early-stage companies in the high-growth sectors of biotechnology, pharmaceuticals, and medical technology. They have a proven track record of identifying emerging bioscience opportunities and transforming them into commercially successful enterprises.

Jeito Capital is a leading global investment company focused on biopharmaceuticals. They finance and accelerate cutting-edge medical innovation with a patient benefit approach, supporting entrepreneurs through significant capital contributions and expert guidance.

Seventure Partners is a leading European venture capital firm with over €1bn under management. They invest in innovative companies in Life Sciences and Digital Technologies, providing funding and support from early to late stages.

Sofinnova Partners is a leading European venture capital firm specializing in life sciences, with a focus on healthcare and sustainability. They invest across the entire value chain, from seed to later-stage, supporting groundbreaking innovations.

Think.Health is a boutique risk-taker investing in disruptive business models within the healthcare sector. They focus on digital healthcare, life sciences, pharmaceuticals, and biotechnology, providing active support and leveraging their extensive network to enable portfolio companies.

Versant Ventures is a global healthcare venture capital firm. They harness the power of science to deliver strong results, managing over $4.2B and boasting 50 IPOs and 46 M&As. Their focus is on biotechnology and pharmaceuticals.